Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Amr Nassar(Jouf University), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Said Mohamed(King Faisal Specialist Hospital & Research Centre), Zubeir Nurgat(King Faisal Specialist Hospital & Research Centre), Tusneem Elhassan(King Faisal Specialist Hospital & Research Centre), Ghada Elgohary(Ain Shams University Hospital)
Cited by 30
Related Papers
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2016|538
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
One million haemopoietic stem-cell transplants: a retrospective observational study
|The Lancet Haematology|2015|434